EPS Creative Health Technology Group Full Year 2025 Earnings: EPS: HK$0.074 (vs HK$0.044 loss in FY 2024)

EPS Creative Health Technology Group (HKG:3860) Full Year 2025 Results

Key Financial Results

• Revenue: HK$544.5m (down 16% from FY 2024).
• Net income: HK$38.6m (up from HK$22.1m loss in FY 2024).
• Profit margin: 7.1% (up from net loss in FY 2024). The move to profitability was driven by lower expenses.
• EPS: HK$0.074 (up from HK$0.044 loss in FY 2024).

We've found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

All figures shown in the chart above are for the trailing 12 month (TTM) period

EPS Creative Health Technology Group shares are down 3.0% from a week ago.

Risk Analysis

Before you take the next step you should know about the 2 warning signs for EPS Creative Health Technology Group (1 is potentially serious!) that we have uncovered.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.